This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Kellogg (K) on Track to Optimize Portfolio With Ferrero Deal
by Zacks Equity Research
Kellogg Company (K) inks deal to divest certain cookies, pie crusts, fruit and fruit-flavored snacks, and ice cream cones businesses to Ferrero.
These Food Stocks Hit 52-Week High: Is Room for Growth Left?
by Zacks Equity Research
General Mills and TreeHouse Foods appear promising on solid growth strategies and favorable industry trends.
5 High-Yielding Stocks for an Uncertain April
by Nalak Das
The first-quarter 2019 performance does not guarantee continued success.
Can Colgate's (CL) Cost-Savings Programs Offset Margin Woes?
by Zacks Equity Research
Colgate (CL) struggles with strained margins for quite a while now. Nevertheless, the company's cost-savings program appears encouraging.
The Zacks Analyst Blog Highlights: Unilever, Medifast, British American Tobacco, Sysco and J.M. Smucker
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Unilever, Medifast, British American Tobacco, Sysco and J.M. Smucker
Zacks.com featured expert Kevin Matras highlights: Medifast, Foot Locker, Comfort Systems, EMCOR and Robert Half International
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Medifast, Foot Locker, Comfort Systems, EMCOR and Robert Half International
Medifast (MED) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Medifast (MED) closed at $127.67 in the latest trading session, marking a -1.08% move from the prior day.
5 Consumer Staples Stocks for an Era of Soft Yields
by Swarup Gupta
Consumer staples are smart choices during a period of soft long-term rates, which signal a near-term economic slowdown.
Depend on DuPont Analysis & Pick 5 Top Stocks
by Sanghamitra Saha
Do you have more faith in DuPont analysis than a simple ROE calculation? Invest in these five best bets then.
United Natural Gains 28% in 3 Months: Buyouts a Key Driver
by Zacks Equity Research
United Natural (UNFI) is on track with its SUPERVALU buyout, which contributes significantly to the top line. However, the company grapples with higher input cost.
Zacks.com featured expert Kevin Matras highlights: Kamada, Herc, Medifast, SkyWest and SP Plus
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Kamada, Herc, Medifast, SkyWest and SP Plus
General Mills Gains 6% Since Q3 Results, Hits 52-Week High
by Zacks Equity Research
General Mills (GIS) is on track with its Consumer First strategy and other cost-reduction initiatives. Also, the company benefits from buyouts, especially Blue Buffalo.
McCormick (MKC) Q1 Earnings Beat Estimates, Sales Improve Y/Y
by Zacks Equity Research
McCormick's (MKC) first-quarter fiscal 2019 results benefit from improved volumes and product mix.
Best 6 Bets With Sound Net Profit Margin to Lift Portfolio
by Zacks Equity Research
Let's take a look at six excellent stocks with handsome net profit margin that can build a winning portfolio.
Sprouts Farmers Down 18% in 6 Months: Will it Decline Further?
by Zacks Equity Research
Sprout Farmers (SFM) is battling elevated SG&A costs and a high debt level. Analysts are also growing bearish on the stock as apparent from downward revision in the Zacks Consensus Estimate
Zacks.com featured expert Kevin Matras highlights: Commvault Systems, Fortinet, Medifast and Evercore
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Commvault Systems, Fortinet, Medifast and Evercore
General Mills (GIS) Beats on Q3 Earnings & Sales, Updates View
by Zacks Equity Research
General Mills (GIS), which is currently focused on Consumer First strategy and cost-reduction initiatives, posts impressive third-quarter fiscal 2019 results.
Invest Carefully Despite a Dovish Fed: 5 Safe Picks
by Nalak Das
The Fed has also reduced the growth projection of U.S. GDP, while raising its previous projection for unemployment.
Grab These 4 Liquid Picks on the Top Rung for Robust Returns
by Zacks Equity Research
Here are four top-notch liquid stocks that investors can count on for superior returns.
Medifast (MED) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Medifast (MED) closed at $131.81 in the latest trading session, marking a +0.02% move from the prior day.
Conagra (CAG) Stock Rises on Q3 Earnings Beat, Sales Miss
by Zacks Equity Research
Conagra's (CAG) bottom line beats the Zacks Consensus Estimate while the top line lags the same in third-quarter fiscal 2019. Also, management revises fiscal 2019 view.
General Mills (GIS) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
General Mills (GIS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Is MEDIFAST INC (MED) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (MED) Outperforming Other Consumer Staples Stocks This Year?
3 Reasons Why Medifast (MED) Is a Great Growth Stock
by Zacks Equity Research
Medifast (MED) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Hain Celestial (HAIN) Down on Weak FY19 Outlook & Soft Margin
by Zacks Equity Research
Hain Celestial's (HAIN) dismal top line and high freight costs are concerns. However, Project Terra is likely to provide cushion to the stock.